The 2011 Leading Pharmaceutical Companies Financial Analyses

October 2010 | 130 pages | ID: LA821142B9EEN
Venture Planning Group

Abstracts

Global PDF: US$ 3,900.00

Each company’s analysis provides:

• U.S. and international sales and operating profit estimates by division, geographic region, therapeutic category, and individual drug.
• Five-year sales and operating profit performance.

The companies analyzed in the report:

        -   AstraZeneca
        -   Bristol-Myers Squibb
        -   GlaxoSmithKline
        -   Johnson & Johnson
        -   Merck
        -   Novartis
        -   Pfizer
        -   Roche
        -   Sanofi-Aventis
        -   Wyeth

Contains 130 pages and 92 tables

Contents

For each company, the analyses provide:

-U.S. and international sales and operating profit estimates by estimates by division, geographic region, therapeutic category, and individual drug.

-Five-year sales and operating profit performance.

List Of Tables

LIST OF TABLES

Table AZ-1: AstraZeneca Sales and Operating Profit Growth
Table AZ-2: AstraZeneca Sales by Therapeutic Category/Business
Table AZ-3: AstraZeneca Sales Growth by Therapeutic Category/business
Table AZ-4: AstraZeneca Sales by Major Drug/Business
Table AZ-5: AstraZeneca Sales Growth by Major Drug/Business
Table AZ-6: AstraZeneca Sales by Major Drug/Business and Geographic Region
Table AZ-7: AstraZeneca Sales by Geographic Region and Country
Table AZ-8: AstraZeneca Sales Growth by Geographic Region and Country
Table BM-1: Bristol-Myers Squibb Sales and Operating Profit Growth
Table BM-2: Bristol-Myers Squibb Sales by Major Division
Table BM-3: Bristol-Myers Squibb Sales by Major Division and Geographic Region
Table BM-4: Bristol-Myers Squibb Sales Growth by Major Division
Table BM-5: Bristol-Myers Squibb Sales by Therapeutic Category
Table BM-6: Bristol-Myers Squibb Sales by Therapeutic Category and Geographic Region
Table BM-7: Bristol-Myers Squibb Sales Growth by Therapeutic Category
Table BM-8: Bristol-Myers Squibb Sales by Major Drug
Table BM-9: Bristol-Myers Squibb Sales Growth by Major Drug
Table BM-10: Bristol-Myers Squibb Sales by Product Line
Table BM-11: Bristol-Myers Squibb Sales Growth by Product Line
Table BM-12: Bristol-Myers Squibb Sales by Geographic Region
Table BM-13: Bristol-Myers Squibb Sales Growth by Geographic Region
Table BM-14: Bristol-Myers Squibb Other Health Care Sales by Product
Table Gl-1: GlaxoSmithKline Sales by Business Segment
Table Gl-2: GlaxoSmithKline Sales Growth by Business Segment
Table Gl-3: GlaxoSmithKline Operating Profit and Margins by Business Segment
Table Gl-4: GlaxoSmithKline Operating Profit by Business Segment
Table Gl-5: GlaxoSmithKline Sales and Operating Profit Growth
Table Gl-6: GlaxoSmithKline Sales by Major Drug
Table Gl-7: GlaxoSmithKline Sales by Drug and Geographic Region
Table Gl-8: GlaxoSmithKline Sales by Therapeutic Category
Table Gl-9: GlaxoSmithKline Sales Growth by Therapeutic Category
Table Gl-10: GlaxoSmithKline Sales by Geographic Region and Country
Table Gl-11: GlaxoSmithKline Sales Growth by Geographic Region
Table Gl-12: GlaxoSmithKline Consumer Healthcare Sales by Product Line
Table Gl-13: GlaxoSmithKline Consumer Healthcare Sales Growth By Product Line
Table JJ-1: Johnson & Johnson Sales by Geographic Region and Country
Table JJ-2: Johnson & Johnson Sales Growth by Geographic Region
Table JJ-3: Johnson & Johnson Sales by Business Segment and Geographic Region
Table JJ-4: Johnson & Johnson Sales and Operating Profit Growth
Table JJ-5: Johnson & Johnson Sales by Major Drug
Table JJ-6: Johnson & Johnson Pharmaceutical Sales Growth by Major Drug
Table JJ-7: Johnson & Johnson Consumer Segment Sales by Product Line
Table JJ-8: Johnson & Johnson Consumer Segment Sales Growth by Product Line
Table ME-1: Merck Sales and Operating Profit Growth
Table ME-2: Merck Sales by Geographic Region
Table ME-3: Merck Sales Growth by Geographic Region
Table ME-4: Merck Sales by Therapeutic Category
Table ME-5: Merck Sales Growth by Therapeutic Category
Table ME-6: Merck Sales by Major Drug
Table ME-7: Merck Sales Growth by Major Drug
Table ME-8: Merck Sales by Major Drug and Geographic Region
Table NO-1: Novartis Sales and Operating Profit Growth
Table NO-2: Novartis Sales by Business Segment
Table NO-3: Novartis Sales Growth by Business Segment
Table NO-4: Novartis Operating Profit by Business Segment
Table NO-5: Novartis Operating Profit Growth by Business Segment
Table NO-6: Novartis Sales by Country
Table NO-7: Novartis Sales Growth by Country